Virax Biolabs Group Ltd (NASDAQ:VRAX) shares are trading higher on abnormally high volume Tuesday after the company announced an agreement for the distribution of an Avian Influenza A Virus (AIV) real ...
The deal includes a monopoly on avian influenza tests in China for three years. Rockeby signed a non-binding but conditional letter of intent with Beijing Anheal Laboratories, a state-backed company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback